Cardiopulmonary Bypass in Neonatal Cardiac Surgery
Cardiopulmonary Bypass in Neonatal Cardiac Surgery
Embedded Files
When an intra-cardiac repair is necessary, the surgeon utilizes cardiopulmonary bypass, which serves as a combined artificial heart and lung. This machine consists of a reservoir to store blood, a pump to maintain flow based on the patient's theoretical requirements, an oxygenator for gas exchange, and a heat exchanger to regulate temperature. To initiate bypass, the patient is first anticoagulated with heparin, and then cannulas are placed to drain venous blood and return oxygenated blood to the ascending aorta. Depending on the surgery, the venous drainage may be performed through a single cannula in the right atrium or through bicaval cannulation of the superior and inferior vena cavae. To protect the heart during the repair, it is arrested using a cardioplegic solution, which may be blood-based and rich in potassium or a crystalloid solution that can provide protection for up to ninety minutes. Surgeries are categorized as either closed-heart, where bypass is not required, or open-heart. Closed-heart procedures include the ligation of a patent ductus arteriosus, repair of an isolated aortic coarctation, and the placement of systemic-to-pulmonary shunts or pacemakers. Open-heart procedures involve more complex intra-cardiac repairs, such as the closure of atrial or ventricular septal defects (ASD or VSD) using autologous or heterologous patches.
The practice of pediatric perfusion in the operating room begins long before the first incision is made, as the team must carefully prepare for the unique requirements of each patient. This process starts with obtaining the patient's height and weight to calculate specific flow requirements during cardiopulmonary bypass (CPB). Based on these calculations and the nature of the cardiac defect, such as major aortopulmonary collaterals that might necessitate increased flow, the perfusionist selects an appropriate circuit and equipment. Once the circuit is set up piece by piece, it is primed with necessary drugs and, if required, blood products. To ensure the blood remains safe during the procedure, it is often processed through a cell saver to wash off high potassium and red blood cell fragments that may have accumulated in stored blood. As the surgical procedure commences, the transition to cardiopulmonary bypass involves a coordinated sequence of events. After the surgeon completes the initial dissection, anesthesia administers a loading dose of heparin to achieve full anticoagulation, which is verified using the activated clotting time (ACT) test.
Cannulation typically involves placing an aortic cannula into the ascending aorta and one or more venous cannulas depending on the complexity of the repair. For intracardiac procedures, bicaval cannulation of the superior and inferior vena cava is utilized to drain the heart completely. Once support is initiated, the venous line is opened to allow blood to return to a reservoir, and the pump flow is increased to drive that blood through an oxygenator and back into the patient's arterial circulation. This mechanical system effectively bypasses the heart and lungs, allowing the pump to handle both circulation and ventilation.
Cardioplegia
Cardioplegia is a fundamental component of cardiac surgery that facilitates the temporary arrest of the heart's electrical and mechanical activity, providing the surgeon with the quiet, bloodless, and motionless field necessary for precise intracardiac repairs. This state of cardiac standstill is initiated only after the heart and lungs have been successfully bypassed by the extracorporeal circuit and an aortic cross-clamp has been applied. The cross-clamp is positioned on the aorta just proximal to the aortic cannula to isolate the heart from the systemic circulation and prevent air from shunting from the right side of the heart to the left, where it could otherwise be ejected into the cerebral vessels. Once the clamp is in place, the rest of the body continues to be perfused by the pump while the heart itself receives the specialized cardioplegic solution. The choice of cardioplegic solution typically falls into two categories: blood-based or crystalloid. Blood-based solutions are frequently rich in potassium and are often mixed with the patient's blood at specific ratios, such as four parts blood to one part solution. These high-potassium solutions generally require subsequent doses every fifteen to thirty minutes to maintain protection and arrest. In contrast, some centers utilize hyperpolarizing crystalloid solutions, such as Custodiol or Celsior.
A significant advantage of these crystalloid solutions is their ability to flush all residual blood out of the heart chambers and provide an extended window of myocardial protection, potentially lasting up to ninety minutes or two hours between doses. This allows the surgical team to work for longer periods without the interruptions required for re-administering the solution. Administration of the solution can occur through different routes depending on the patient's anatomy and the specific surgical requirements. The most common method in pediatric cardiac surgery is anterograde delivery, where the solution is injected into the ascending aorta to perfuse the coronary arteries in the natural direction of flow. In some complex cases, particularly in adult surgery, a retrograde approach may be used by cannulating the coronary sinus and delivering the solution in reverse. Regardless of the route, the solution is typically delivered very cold, often at 10 degrees Celsius or lower, to provide additional protection to the myocardium by reducing its metabolic and energy requirements. These solutions also contain components that assist with energy production after the cross-clamp is removed, ensuring the heart has an adequate energy source for recovery. While cardioplegia is essential for the surgical repair, it introduces physiological challenges that the perfusionist must actively manage. Because crystalloid solutions are often low in sodium and calcium, they can disrupt the patient's electrolyte balance as they mix with the circulating blood in the reservoir. This imbalance, if left uncorrected, can lead to complications such as tissue edema. At the conclusion of the intra-cardiac repair, the team begins the process of de-airing the heart and rewarming the patient. Once the heart is closed and the air is removed, the aortic cross-clamp is released, allowing warm, oxygenated blood to reperfuse the myocardium. This reperfusion washes out the cardioplegic solution and restores the heart's electrolyte balance, which usually results in a spontaneous return of the heart's rhythm without the need for significant mechanical stimulation.
Hypothermia
In pediatric cardiac surgery, hypothermia is a foundational technique used to protect the patient's vital organs and the heart itself by significantly reducing metabolic demand and oxygen consumption during complex repairs. This process is managed by the perfusionist through a heat exchanger integrated into the cardiopulmonary bypass circuit, allowing for precise control of the patient's blood temperature. While some surgeries are performed under normothermia (maintaining a temperature of 36–37°C), many cases require cooling to mitigate the risks associated with prolonged operative times or the need for reduced blood flow. The degree of cooling is tailored to the complexity of the surgical procedure. Deep hypothermia, typically defined between 18°C and 24°C, is reserved for the most intricate repairs, such as aortic arch reconstructions or the Norwood procedure. At these extremely low temperatures, surgeons can safely employ deep hypothermic circulatory arrest (DHCA), where the heart-lung machine is stopped entirely to provide a motionless, bloodless field without damaging the brain or other organs. Alternatively, deep hypothermia may be paired with selective cerebral perfusion, where oxygenated blood is directed specifically to the head vessels while the rest of the body's circulation is paused. Beyond organ protection, cooling the patient allows the perfusionist to reduce the overall pump flow rate, which helps prevent the surgical field from being "flooded" with blood, thereby improving the surgeon's visibility during delicate intracardiac work. Despite its protective benefits, hypothermia introduces several clinical challenges and trade-offs. One primary downside is the increased duration of the procedure, as cooling and rewarming the patient are gradual processes that add significant time to the bypass run. Furthermore, hypothermia is known to interfere with the body's coagulation system, often leading to increased post-operative bleeding compared to normothermic procedures. Because of these risks, some modern programs have shifted toward a hybrid approach, utilizing high-flow bypass at more moderate temperatures—typically not going lower than 30°C—to reduce bypass times and minimize bleeding complications. The management of temperature continues into the transition from the operating room to the intensive care unit. As the surgical repair concludes, the perfusionist begins rewarming the patient by circulating warm blood through the heat exchanger. However, patients who have been cooled dramatically often experience a secondary dip in temperature once they reach the ICU. Even if they appear normothermic upon leaving the operating room, their temperature can drop to as low as 33°C shortly after arrival, a trend that intensivists must monitor closely to ensure hemodynamic stability and proper recovery.
Bypass and cross-clamping
A critical component of the bypass phase is the application of the aortic cross-clamp, which is necessary for any repair requiring access to the interior of the heart or the aortic arch. The clamp is placed proximal to the aortic cannula to prevent air from shunting from the right side of the heart to the left, where it could be ejected into the cerebral vessels. Once the clamp is applied, the heart is isolated and receives the cold cardioplegic solution while the rest of the body is perfused by the pump. Because these crystalloid solutions can be low in sodium and calcium, they often mix with the circulating blood and can disrupt electrolyte balance, which the perfusionist must monitor and correct to prevent issues like tissue edema.
End of surgery
The conclusion of the bypass run is a delicate balancing act that requires constant communication between the perfusionist, surgeon, and anesthesiologist. As the repairs are completed, the patient is rewarmed, the heart is de-aired, and the cross-clamp is removed to allow warm, oxygenated blood to reperfuse the myocardium. This usually leads to a spontaneous return of the heart's rhythm. The team then gradually transfers the workload from the machine back to the patient's heart and lungs, with anesthesia resuming ventilation as the venous line is slowly clamped. During this weaning phase, the team targets specific hemodynamic goals, such as a higher hematocrit for single-ventricle patients, to ensure a stable transition. To optimize the patient's status immediately following bypass, techniques like modified ultrafiltration (MUF) are employed. MUF utilizes a hemo-concentrator to remove excess fluid from the patient while concentrating the hemoglobin and returning essential platelets and plasma proteins from the residual pump volume. This process is particularly beneficial in pediatrics because it allows the team to provide blood products like cryoprecipitate or platelets while simultaneously pulling off volume, thereby avoiding the hemodynamic shifts that can occur if these products are given as boluses.
Additionally, while a cell saver device is available to scavenge and wash blood spilled into the surgical field, its use in small pediatric patients is often limited because there is rarely enough volume to process. The information relayed from the operating room to the intensive care unit (ICU) is vital for the patient’s postoperative management. Intensivists should be aware of the total bypass and cross-clamp times, as longer durations are often associated with increased risks of bleeding and impaired organ function. Temperature trends are also important; even if a patient is rewarmed in the OR, they may experience a secondary dip in temperature once they reach the ICU. Furthermore, if high doses of vasopressors/inotropes were required while on bypass to maintain pressure, this information helps the ICU team anticipate potential hemodynamic instability.
Monitoring
Modern perfusion technology has introduced advanced monitoring to protect the end-organs during these complex procedures. Perfusionists now use sensors to calculate real-time oxygen delivery (DO2), with a target value of at least 272 to help predict and prevent acute kidney injury. This is complemented by monitoring urine output and utilizing near-infrared spectroscopy (NIRS) to track oxygenation in the brain and kidneys. For complex arch repairs, techniques like antegrade cerebral perfusion have largely replaced full circulatory arrest, allowing for continuous blood flow to the brain even when the rest of the body's circulation is paused. Ultimately, the perfusionist serves as a highly trained specialist whose expertise in circuit mechanics and troubleshooting is a valuable resource for the entire multidisciplinary team, both in and out of the operating room.
References
Page updated
Google Sites
Report abuse